i remember reading a post several months ago regarding a snippet of news in the financial review regarding a take over in november and the price being around 60 cents.
perhaps all the ceo's are away negotiating the deal rather than being at a bio pharma meeting in sydney
Add to My Watchlist
What is My Watchlist?